Eosinophilic Esophagitis Market, by Drug Class, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2024

Description

Global eosinophilic esophagitis market is estimated to be valued at USD 237.5 Mn in 2024 and is expected to exhibit a CAGR of 33.2% during the forecast period (2024-2031).

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 237.5 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	33.20%	2030/2031 Value Projection:	US$ 1,767.2 Mn

Global Eosinophilic Esophagitis Market Value (USD Mn), by Region, 2024

Eosinophilic esophagitis is a chronic condition which is treated with the help of steroids and acid suppressants such as proton pump inhibitors. Steroids help control the inflammation. Topical steroids are administered as a inhaler or as a liquid. Oral steroids may be prescribed to treat people who have serious swallowing problems or weight loss. Proton pump inhibitors help with reflux symptoms and decrease inflammation.

Market Dynamics

Growing awareness regarding eosinophilic esophagitis leads to an increase in demand for treatment products. Thus, key market players are engaged in developing newer treatments and addressing the demand for EoE treatment products. For instance, Sanofi S.A. a global biopharmaceutical company engaged in conducting a phase 3 clinical trial for Dupixent (dupilumab) and is estimated to complete by 2023. Additionally, upcoming innovative products to improve the management of EoE are anticipated to drive the global market growth. For instance, in December 2021, Takeda Pharmaceutical Company Limited a Japanese multinational pharmaceutical company received a Complete Response Letter (CRL) for TAK-721 (budesonide oral suspension) from the U.S. Food and Drug Administration (FDA) for the treatment of eosinophilic esophagitis. In June 2021, the U.S. FDA granted Orphan Drug Designation (ODD) for Etrasimod. Etrasimod had been investigated by Arena Pharmaceuticals, Inc. an American biopharmaceutical company. Moreover, an increase in the prevalence of eosinophilic esophagitis is likely boost the market growth. For instance, according to a study published in the Saudi Medical Journal in July 2018, eosinophilic esophagitis is an emerging disease and has an increasing incidence in children in Saudi Arabia.

Key features of the study:

This report provides an in-depth analysis of the global eosinophilic esophagitis market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global eosinophilic esophagitis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
Key companies covered as a part of this study include Ellodi Pharmaceuticals, EsoCap AG, GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd., Cipla Limited, Sun Pharmaceutical Industries Limited, AstraZeneca Plc, Sanofi S.A., Arena Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Revolo Biotherapeutics, Allakos Inc., Bristol-Myers Squibb Co, Calypso Biotech, DBV Technologies, Landos Biopharma, Inc., Glenmark Pharmaceuticals, Alkem Laboratories Ltd., Quorum Innovations LLC, and Dr. Falk Pharma GmbH
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global eosinophilic esophagitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global eosinophilic esophagitis

Detailed Segmentation:

Global Eosinophilic Esophagitis Market, By Drug Class:
- Corticosteroids
- Budesonide
- Jorveza
- Off-label budesonide
- Fluticasone
- Proton Pump Inhibitor (PPI)
- Omeprazole
- Esomeprazole
- Others
- Late Stage Pipeline Drugs
- Dupixent
- APT-1011
- Lirentelimab (AK002)
- Cendakimab
- Etrasimod
- TAK-721
- Omilancor (BT-11)
Global Eosinophilic Esophagitis Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Eosinophilic Esophagitis Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- GlaxoSmithKline plc
- Ellodi Pharmaceuticals
- EsoCap AG
- Teva Pharmaceutical Industries Ltd.
- Cipla Limited
- Sun Pharmaceutical Industries Limited
- AstraZeneca Plc
- Sanofi S.A.
- Arena Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- Revolo Biotherapeutics
- Allakos Inc.
- Bristol-Myers Squibb Co
- Calypso Biotech
- DBV Technologies
- Landos Biopharma, Inc.
- Glenmark Pharmaceuticals
- Alkem Laboratories Ltd.
- Quorum Innovations LLC
- Dr. Falk Pharma GmbH

Product Code: CMI4909

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Drivers
Restraints
Opportunities
Impact Analysis
Pipeline Analysis
Regulatory Scenario
Recent Product Approval/Launch
PEST Analysis
Epidemiology

4. Global Eosinophilic Esophagitis Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply and Demand Analysis
Key Developments

5. Global Eosinophilic Esophagitis Market, By Drug Class, 2019 - 2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
Budesonide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Million)
Jorveza

1. Introduction

2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Million)

Off-label budesonide

1. Introduction

2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Million)

Fluticasone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Million)
Proton Pump Inhibitor (PPI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
Omeprazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Million)
Esomeprazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Million)
Late Stage Pipeline Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
Dupixent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Million)
APT-1011
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Million)
Lirentelimab (AK002)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Million)
Cendakimab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Million)
Etrasimod
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Million)
TAK-721
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Million)
Omilancor (BT-11)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Million)

6. Global Eosinophilic Esophagitis Market, By Distribution Channel, 2019 - 2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)

7. Global Eosinophilic Esophagitis Market, By Region, 2019 - 2031, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Mn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (US$ Mn)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Ellodi Pharmaceuticals.
Company Highlights
Product Portfolio
Key Highlights
Strategies
- EsoCap AG
Company Highlights
Product Portfolio
Key Highlights
Strategies
- GlaxoSmithKline plc.
- Teva Pharmaceutical Industries Ltd
- Cipla Limited
- Sun Pharmaceutical Industries Limited
- AstraZeneca Plc
- Sanofi S.A.
- Arena Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- Revolo Biotherapeutics
- Allakos Inc.
- Bristol-Myers Squibb Co
- Calypso Biotech
- DBV Technologies
- Landos Biopharma, Inc.
- Glenmark Pharmaceuticals
- Alkem Laboratories Ltd.
- Quorum Innovations LLC
- Falk Pharma GmbH

9. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. Section

References
Research Methodology
About Us and Sales Contact

Eosinophilic Esophagitis Market, by Drug Class, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031

Description

Table of Contents

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Eosinophilic Esophagitis Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Eosinophilic Esophagitis Market, By Drug Class, 2019 - 2031, (US$ Mn)

1. Introduction

2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Million)

1. Introduction

2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Million)

6. Global Eosinophilic Esophagitis Market, By Distribution Channel, 2019 - 2031, (US$ Mn)

7. Global Eosinophilic Esophagitis Market, By Region, 2019 - 2031, (US$ Mn)

8. Competitive Landscape

9. Analyst Recommendation

10. Section